The number of drugs in short supply has reached 180, delaying critical treatment for patients and pushing up health care costs as doctors scramble to find alternatives. Manufacturing problems, business decisions and supply-chain delays contribute to the problem, experts say. Tax incentives, streamlined regulations and stockpiling raw materials could help alleviate the problem, according to the Generic Pharmaceutical Association.

Full Story:
USA Today

Related Summaries